MASUI
VKTX icon

MIRAE ASSET SECURITIES (USA) INC.’s Viking Therapeutics VKTX Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,700
Closed -$1.42M – 251
2025
Q2 		$1.42M Buy
+53,700
New +$1.41M 0.04% 173
2025
Q1 		– Sell
-33,800
Closed -$1.36M – 264
2024
Q4 		$1.36M Hold
33,800
– – 0.04% 132
2024
Q3 		$2.14M Buy
+33,800
New +$1.98M 0.09% 109

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s VKTX Position: Q3 2025 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Viking Therapeutics (VKTX) in Q3 2025, closing a stake of 53,839 shares — an estimated $1.43M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in VKTX in Q3 2024 and held it in 3 quarters. The position peaked at $2.15M in Q3 2024. 370 funds tracked by Wall St. Rank hold VKTX as of Q3 2025.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Viking Therapeutics position as of Q3 2025 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 53,839 Viking Therapeutics shares in Q3 2025, an estimated $1.43M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Viking Therapeutics in Q3 2024 and held it in 3 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Viking Therapeutics position peaked at $2.15M in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2025.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q3 2025, filed 24 Oct 2025.